(Q36282233)

13 August 2017

1 reference

title

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis (English)

1 reference

lymphoproliferative disorders

13 August 2017

0 references

1 reference

3

Gianluca Gaidano

1 reference

13 August 2017

Daniela Capello

1

1 reference

13 August 2017

Davide Rossi

series ordinal

2

1 reference

13 August 2017

publication date

1 June 2005

1 reference

13 August 2017

published in

Hematological Oncology

1 reference

13 August 2017

volume

23

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

61-67

1 reference

Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells

13 August 2017

cites work

1 reference

The inference of antigen selection on Ig genes

21 January 2018

1 reference

Overview of the epidemiology of immunodeficiency-associated cancers

21 January 2018

1 reference

7 January 2021

Primary malignancy in patients undergoing immunosuppression for renal transplantation

1 reference

7 January 2021

Diagnosis and treatment of transplant-related lymphoma

1 reference

7 January 2021

Identifying the patient at risk for post-transplant lymphoproliferative disorder

1 reference

7 January 2021

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

7 January 2021

The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant

1 reference

7 January 2021

Molecular histogenesis of posttransplantation lymphoproliferative disorders

1 reference

7 January 2021

Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas

1 reference

7 January 2021

Cellular origin of human B-cell lymphomas.

1 reference

7 January 2021

The occurrence and significance of V gene mutations in B cell-derived human malignancy

1 reference

7 January 2021

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

1 reference

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes

1 reference

7 January 2021

MUM1: a step ahead toward the understanding of lymphoma histogenesis.

1 reference

7 January 2021

Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes

1 reference

7 January 2021

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

1 reference

7 January 2021

Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications

1 reference

7 January 2021

The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement

1 reference

7 January 2021

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

1 reference

7 January 2021

Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.

1 reference

7 January 2021

Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases

1 reference

7 January 2021

The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease

1 reference

7 January 2021

The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis

1 reference

7 January 2021

B cells under influence: transformation of B cells by Epstein–Barr virus

1 reference

7 January 2021

Epstein-Barr virus and cancer

1 reference

7 January 2021

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

7 January 2021

Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders

1 reference

7 January 2021

Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study

1 reference

7 January 2021

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD

1 reference

7 January 2021

Treatment of EBV-Related Post-Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV-Specific T Cells

1 reference

7 January 2021

Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities

1 reference

7 January 2021

Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis

1 reference

7 January 2021

Presence of simian virus 40 DNA sequences in human lymphomas

1 reference

7 January 2021

Association between simian virus 40 and non-Hodgkin lymphoma

1 reference

7 January 2021

Simian virus 40 infection in lymphoproliferative disorders

1 reference

7 January 2021

Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma

1 reference

7 January 2021

Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States

1 reference

7 January 2021

The mutator pathway is a feature of immunodeficiency-related lymphomas

1 reference

7 January 2021

Molecular biology of Burkitt's lymphoma

1 reference

7 January 2021

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

1 reference

7 January 2021

Direct activation of TERT transcription by c-MYC.

1 reference

7 January 2021

c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene

1 reference

7 January 2021

Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6

1 reference

7 January 2021

Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders

1 reference

7 January 2021

DNA methylation and cancer

1 reference

7 January 2021

Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.

1 reference

7 January 2021

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

7 January 2021

DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death

1 reference

7 January 2021

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

1 reference

7 January 2021

Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation

1 reference

7 January 2021

Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma

1 reference

7 January 2021

Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders.

1 reference

7 January 2021

Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma

1 reference

7 January 2021

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1 reference

7 January 2021

Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant

1 reference

7 January 2021

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.751

1 reference

13 August 2017

1 reference